The TRANSCEND-T2D Phase 3 program is investigating its efficacy and safety in adults with type 2 diabetes
The three receptors to which retatrutide binds function as follows: GLP-1: Enhances satiety, reduces appetite, and promotes insulin secretion, directly supporting weight loss and blood glucose regulation
After removing duplicates, we screened 97 records for eligibility criteria
However, most of these studies used standard doses approved for diabetes or obesity, and dedicated trials examining low-dose GLP-1 specifically for inflammatory conditions are lacking
These regular check-ins help guide whether your dose should stay the same, increase slightly, or, in some cases, decrease to keep things manageable
Panda Peptide supplies research-grade peptides to licensed Canadian researchers